相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology
Tetsuhiro Chiba et al.
HEPATOLOGY RESEARCH (2016)
The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin
Kiyohito Kato et al.
ONCOLOGY REPORTS (2016)
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
Takuma Higurashi et al.
LANCET ONCOLOGY (2016)
The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy
Younak Choi et al.
CANCER RESEARCH AND TREATMENT (2016)
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
Andrea Casadei Gardini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo
Shintaro Fujihara et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma
Hamza Chettouh et al.
LIVER INTERNATIONAL (2015)
Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies
Takayuki Fujimori et al.
ONCOLOGY REPORTS (2015)
Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers
Susan B. Brown et al.
STEROIDS (2015)
Research progress and prospects of markers for liver cancer stem cells
Cheng-Pei Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Short- and long-term outcomes of hepatectomy with or without radiofrequency-assist for the treatment of hepatocellular carcinomas: a retrospective comparative cohort study
Rui Guo et al.
BIOSCIENCE TRENDS (2015)
Cancer Risk Among People With Type 1 and Type 2 Diabetes: Disentangling True Associations, Detection Bias, and Reverse Causation
Jessica L. Harding et al.
DIABETES CARE (2015)
Emerging Trends in Hepatocellular Carcinoma Incidence and Mortality
Basile Njei et al.
HEPATOLOGY (2015)
miRNA in hepatocellular carcinoma
Asahiro Morishita et al.
HEPATOLOGY RESEARCH (2015)
Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes-National cohort of Taiwan Diabetes Study
Chia-Ing Li et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo
Xianbin Cai et al.
PLOS ONE (2015)
Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
Sean F. Altekruse et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle
Jacqueline M. Major et al.
ANNALS OF EPIDEMIOLOGY (2014)
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
Jisun Kim et al.
BMC CANCER (2014)
Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders
Sara Gandini et al.
CANCER PREVENTION RESEARCH (2014)
Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
Konstantinos K. Tsilidis et al.
DIABETES CARE (2014)
Diabetes and cancer: two diseases with obesity as a common risk factor
S. K. Garg et al.
DIABETES OBESITY & METABOLISM (2014)
Continuation of Metformin Use After a Diagnosis of Cirrhosis Significantly Improves Survival of Patients With Diabetes
Xiaodan Zhang et al.
HEPATOLOGY (2014)
Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
Hisaaki Miyoshi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Role of estrogen in hepatocellular carcinoma: is inflammation the key?
Liang Shi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Eric Lawitz et al.
LANCET (2014)
Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status
Shigetoshi Naito et al.
LIVER INTERNATIONAL (2014)
Contextual inhibition of fatty acid synthesis by metformin involves glucose-derived acetyl-CoA and cholesterol in pancreatic tumor cells
Mary Jo Cantoria et al.
METABOLOMICS (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Yan-Gang Wang et al.
PLOS ONE (2014)
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
Y. Feng et al.
CELL DEATH & DISEASE (2014)
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Monica Enguita-German et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
microRNAs and cancer metabolism reprogramming: the paradigm of metformin
Claudio Pulito et al.
ANNALS OF TRANSLATIONAL MEDICINE (2014)
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
S. Schlesinger et al.
ANNALS OF ONCOLOGY (2013)
Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
W-P Koh et al.
BRITISH JOURNAL OF CANCER (2013)
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Eileen M. Moore et al.
DIABETES CARE (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
MicroRNA-140-5p Suppresses Tumor Growth and Metastasis by Targeting Transforming Growth Factor β Receptor 1 and Fibroblast Growth Factor 9 in Hepatocellular Carcinoma
Hao Yang et al.
HEPATOLOGY (2013)
MicroRNA-140 acts as a liver tumor suppressor by controlling NF-kappa B activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression
Akemi Takata et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Obesity, adipokines and hepatocellular carcinoma
Xiao-Feng Duan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Antitumor effect of metformin in esophageal cancer: In vitro study
Mitsuyoshi Kobayashi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey
Kiyoshi Hasegawa et al.
JOURNAL OF HEPATOLOGY (2013)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Ana Chocarro-Calvo et al.
MOLECULAR CELL (2013)
Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
Bindiya Thakkar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis
Ming Yin et al.
ONCOLOGIST (2013)
Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo
Xianbin Cai et al.
ONCOLOGY REPORTS (2013)
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
Tomoko Saito et al.
PLOS ONE (2013)
Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II
Barbara Salani et al.
SCIENTIFIC REPORTS (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
Shanchun Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
Carolyn Algire et al.
CANCER PREVENTION RESEARCH (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
Weiguang Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
Ping Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
J. A. Johnson et al.
DIABETOLOGIA (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Jin Ha Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Management of HCC
Carlos Rodriguez de Lope et al.
JOURNAL OF HEPATOLOGY (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Prognostic Influence of Metformin as First-Line Chemotherapy for Advanced Nonsmall Cell Lung Cancer in Patients With Type 2 Diabetes
Ben-Xu Tan et al.
CANCER (2011)
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
Isaam Ben Sahra et al.
CANCER RESEARCH (2011)
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
Assiamira Ferrara et al.
DIABETES CARE (2011)
Meta-analysis of trial data may support a causal role of hyperglycaemia in cancer
X. L. Yang et al.
DIABETOLOGIA (2011)
Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
J. A. Johnson et al.
DIABETOLOGIA (2011)
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
J. A. Johnson et al.
DIABETOLOGIA (2011)
Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
Anna S. Lok et al.
GASTROENTEROLOGY (2011)
No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus
Andrea Snow-Lampart et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
Hirokazu Takahashi et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
Hans-Werner Hense et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
Susen Becker et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11)
Gijs W. Landman et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2010)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
Kunihiro Hosono et al.
CANCER PREVENTION RESEARCH (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
P. D. Home et al.
DIABETOLOGIA (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
Alan P. Venook et al.
ONCOLOGIST (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003
Hideo Tanaka et al.
ANNALS OF INTERNAL MEDICINE (2008)
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
Patrick Marcellin et al.
HEPATOLOGY (2008)
Global burden of obesity in 2005 and projections to 2030
T. Kelly et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Cancer stem cells: A step toward the cure
Bruce M. Boman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis
Yusuke Kawamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Warburg revisited: imaging tumour blood flow and metabolism
K. A. Miles et al.
CANCER IMAGING (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis
Takuya Komura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection
Li Zhou et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: Comparison with Japanese-Americans and US whites
Hideo Tanaka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Liver transplantation for hepatocellular carcinoma in Asia
Vanessa De Villa et al.
ONCOLOGIST (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Diabetes mellitus and the risk of cancer - Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less
SM Lin et al.
GUT (2005)
Prognostic impact of anatomic resection for hepatocellular carcinoma
K Hasegawa et al.
ANNALS OF SURGERY (2005)
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
S Shiina et al.
GASTROENTEROLOGY (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
JM Lizcano et al.
EMBO JOURNAL (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
GD Batty et al.
CANCER CAUSES & CONTROL (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus - Systematic review and meta-analysis
SR Salpeter et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk
MW Yu et al.
HEPATOLOGY (2003)
A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway
N Kimura et al.
GENES TO CELLS (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function - Implications for a strategy of salvage transplantation
RTP Poon et al.
ANNALS OF SURGERY (2002)
Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma
JM Regimbeau et al.
SURGERY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin
T Takano et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Hyperinsulinemia predicts fetal liver cancer but is inversely associated with fatal cancer at some other sites -: The Paris Prospective Study
B Balkau et al.
DIABETES CARE (2001)
Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States
HB El-Serag et al.
HEPATOLOGY (2001)
A prospective study of obesity and cancer risk (Sweden)
A Wolk et al.
CANCER CAUSES & CONTROL (2001)
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
YF Liaw et al.
GASTROENTEROLOGY (2000)
分享论文
